A carregar...
Loss of Efficacy of Pasireotide After its Re-Administration: is There a Reason Why?
Pasireotide is a recently approved medical treatment for persistent or recurrent Cushing’s disease (CD). However, an escape from the initial successful response has not yet been described. A 42-year-old female presented with several symptoms indicative of hypercortisolism. Biochemical evaluation and...
Na minha lista:
| Publicado no: | Rare Tumors |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
PAGEPress Publications, Pavia, Italy
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226048/ https://ncbi.nlm.nih.gov/pubmed/28191290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2016.6489 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|